直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Lost Contracts to Perform Work on the High Seas Do Not Justify Lost Profits Damages

July 15, 2015

Authored and Edited by Kara A. Specht; Elizabeth D. Ferrill; Jeff T. Watson

In WesternGeco L.L.C. v. ION Geophysical Corp., Nos. 13-1527, 14-1121, 14-1526, 14-1528 (Fed. Cir. July 2, 2015), the Federal Circuit affirmed the district court’s award of a reasonable royalty based on infringement under 35 U.S.C. § 271(f), but reversed its award of lost profits resulting from conduct occurring abroad.

The district court awarded WesternGeco L.L.C. over $93 million in lost profits based on ten service contracts for seismic surveys, performed on the high seas, which WesternGeco alleged it would have been awarded but for ION Geophysical Corp.’s sales of the infringing product to its customers who won the contracts. ION appealed the lost profits award, arguing that the contracts were to perform work on the high seas, outside the jurisdictional reach of the U.S. patent law.

The Court held that WesternGeco could not recover lost profits resulting from its failure to win foreign service contracts.  Relying on Power Integrations, Inc. v. Fairchild Semiconductor, Int’l, the Court held that U.S. patent laws do not “provide compensation for a defendant’s foreign exploitation of a patented invention, which is not infringement at all.”  The Court explained: “Just as the United States seller or exporter of a final product cannot be liable for use abroad, so too the United States exporter of the component parts cannot be liable for use of the infringing article abroad.” The Court found that a reasonable royalty was the proper remedy for foreign uses of the patented invention.

In a dissent, Judge Wallach wrote that he would have held that the patent statute requires consideration of lost foreign sales when determining damages for infringement under 35 U.S.C. § 271(f).

Tags

lost profits

Contacts

Kara A. Specht
Partner
Atlanta, GA
+1 404 653 6481
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP